Home

Foresite Capital Fund III, L.P.

CIK 1645158 · last filed 2021-11-03

Foresite Capital Fund III, L.P. is a corporate insider who has filed 5 SEC Form 4 insider transactions across 3 companies since 2016. The most recent filing, for ACRS, was dated Nov 3, 2021. Across all open-market trades the lifetime net is −$115.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $5.3M across reported positions. The firm reports its address in San Francisco, CA. 23 SEC filings were submitted jointly with James B. Tananbaum.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$5.35M

Companies

3

Total Filings

5

Lifetime Open-Market Net

-$115.89M

Filer Profile

Reported Address
600 MONTGOMERY STREET
SUITE 4500
SAN FRANCISCO, CA 94111
Phone
(415) 877-4887
State of Incorporation
DE
Related Filers
James B. Tananbaum — 23 joint filings, latest 2021-11-03
Foresite Capital Fund II, L.P. — 20 joint filings, latest 2020-03-02
Foresite Capital Management II, LLC — 20 joint filings, latest 2020-03-02
Foresite Capital Fund IV, L.P. — 10 joint filings, latest 2021-11-03
Foresite Capital Management IV, LLC — 10 joint filings, latest 2021-11-03
Foresite Capital Fund V, L.P. — 2 joint filings, latest 2021-11-03
Foresite Capital Management V, LLC — 2 joint filings, latest 2021-11-03
FS Development Holdings II, LLC — same reported address
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ACRS 10%+ Owner 0 $5.32 $0 $0 1 2021-11-03
AERIE PHARMACEUTICALS INC (AERI) Delisted 10%+ Owner 1,369,938 $15.25 $20.89M -$97.61M 3 2020-03-02
COLL 10%+ Owner 235,020 $22.75 $5.35M -$18.27M 1 2016-06-02

Recent Filings

5 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2021-11-03 ACRS Other (J) −13,626,396 $0 EDGAR
2020-03-02 AERIE PHARMACEUTICALS INC (AERI) Delisted Sell (S) −7,000,000 -$119.49M EDGAR
2016-10-07 AERIE PHARMACEUTICALS INC (AERI) Delisted — — $0 EDGAR
2016-07-26 AERIE PHARMACEUTICALS INC (AERI) Delisted Buy (P) +1,250,000 $21.88M EDGAR
2016-06-02 COLL Sell (S) −1,200,000 -$18.27M EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.